MKI67 and neoplasm: This enhancement in tdLN lymphoproliferation was noted at each day of CPR treatment, as we observed increased lymphocyte percentages and Ki67 expression at days 23, 33, and 37 of treatment compared to tumor size-matched control mice (Additional file 8: Figure S8A, Additional file 9: Figure S9A and Additional file 10: Figure S10).